Joyce Reyes - Jun 1, 2022 Form 3 Insider Report for Histogen Inc. (HSTO)

Role
Senior Vice President of Regulatory, Quality and Technical Operations
Signature
/s/ Susan A. Knudson as attorney-in-fact for Joyce Reyes
Stock symbol
HSTO
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
3
Date filed
6/3/2022, 04:28 PM
Next filing
Apr 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HSTO Stock Option (right to buy) Jun 1, 2022 Common Stock 1.2K $4.80 Direct F1, F2
holding HSTO Stock Option (right to buy) Jun 1, 2022 Common Stock 4.45K $4.80 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On June 2, 2022, the Issuer effected a 1-for-20 reverse stock split of its common stock (the "Reverse Stock Split"). The amounts of securities reported on this Form 3 and the exercise prices have been adjusted to reflect the Reverse Stock Split.
F2 1/4 of the shares subject to the option vest one year after the date of grant, on 9/15/2022, and the remaining 1/36 of the shares vest on a monthly basis thereafter.
F3 1/4 of the shares subject to the option vest one year after the date of grant, on 2/17/2023, and the remaining 1/36 of the shares vest on a monthly basis thereafter.

Remarks:

Senior Vice President of Regulatory, Quality and Technical Operations